DADC
EDIT icon

D.A. Davidson & Co’s Editas Medicine EDIT Stock Holding History

D.A. Davidson & Co’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,315
Closed -$218K – 1277
2021
Q3 		$218K Sell
5,315
-80
-1% -$4.38K ﹤0.01% 1129
2021
Q2 		$306K Sell
5,395
-6,276
-54% -$232K ﹤0.01% 987
2021
Q1 		$490K Sell
11,671
-2,121
-15% -$121K 0.01% 814
2020
Q4 		$967K Buy
13,792
+1,309
+10% +$53.8K 0.01% 518
2020
Q3 		$350K Buy
12,483
+729
+6% +$23.7K 0.01% 725
2020
Q2 		$348K Sell
11,754
-173
-1% -$4.52K 0.01% 711
2020
Q1 		$237K Buy
11,927
+2,332
+24% +$58.8K ﹤0.01% 822
2019
Q4 		$284K Buy
+9,595
New +$240K ﹤0.01% 842
2019
Q2 		– Sell
-8,987
Closed -$220K – 1038
2019
Q1 		$220K Buy
+8,987
New +$203K ﹤0.01% 1011
2018
Q4 		– Sell
-10,119
Closed -$322K – 1113
2018
Q3 		$322K Sell
10,119
-6,485
-39% -$210K 0.01% 883
2018
Q2 		$595K Buy
16,604
+502
+3% +$17.8K 0.01% 639
2018
Q1 		$534K Buy
16,102
+7,417
+85% +$264K 0.01% 657
2017
Q4 		$267K Buy
+8,685
New +$219K 0.01% 892

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

D.A. Davidson & Co's EDIT Position: Q4 2021 in Review

D.A. Davidson & Co sold out of Editas Medicine (EDIT) in Q4 2021, closing a stake of 5,315 shares — an estimated $218K sold.

D.A. Davidson & Co first reported a position in EDIT in Q4 2017 and held it in 13 quarters. The position peaked at $967K in Q4 2020. 305 funds tracked by Wall St. Rank hold EDIT as of Q4 2021.

  • D.A. Davidson & Co reported no remaining Editas Medicine position as of Q4 2021 after selling out during the quarter.
  • D.A. Davidson & Co sold 5,315 Editas Medicine shares in Q4 2021, an estimated $218K.
  • D.A. Davidson & Co first reported a position in Editas Medicine in Q4 2017 and held it in 13 quarters.
  • D.A. Davidson & Co's Editas Medicine position peaked at $967K in Q4 2020.
  • 305 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2021.

Based on D.A. Davidson & Co's 13F filing for Q4 2021, filed 31 Jan 2022.